AbbVie Inc. Profile Avatar - Palmy Investing

AbbVie Inc.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psori…

Drug Manufacturers - General
US, North Chicago [HQ]

Lobbying Analysis

History

Download
FY Quarter Expense For Lobby Disclosure LDA Reference
2023 4 $5,000,000 LD-2 : 01/22/24
2023 4 $6,000,000 LD-2 : 01/20/24
2023 4 $5,000,000 LD-2 : 01/19/24
2023 4 $6,000,000 LD-2 : 01/15/24
2023 4 $6,000,000 LD-2 : 01/13/24

Get PRO Today

With PRO you will unlock 15 more lobbying disclosures for AbbVie Inc.

End of ABBV's Analysis
CIK: 1551152 CUSIP: 00287Y109 ISIN: US00287Y1091 LEI: - UEI: -
Secondary Listings